Like the steroid and thyroid hormone-receptor superfamily, the aryl hydrocarbon receptor (AhR) acts as a nuclear ligand-responsive transcription factor (LTF). The signal transduction mechanism associated with the liganded AhR is a complicated multistep process which occurs in both the cytosolic and nuclear cellular compartments. Based on previous studies and preliminary results, 4 different structural classes of antagonists will be synthesized and investigated and these include alpha- naphthoflavone (alphaNF), 6-substituted-1,3,8-trichlorodibenzofurans (triCDFs), 4'-substituted flavones (F), and 6- and 7-substituted benzocoumarins (Experiment l). The effects of the 4 different structural classes of antagonists on the TCDD-mediated transformation of the AhR will be investigated by determining the kinetics of binding to a synthetic 32P- labeled dioxin responsive element (DRE, 26-mer-duplex) using the gel mobility shift assay. The stoichiometry of the formation of nuclear AhR complexes will be measured in the 4 model cells lines using [3H]TCDD as a ligand and representative model antagonists. This approach will allow the quantitative determination of (i) the total nuclear DRE-binding components (gel shift assay), (ii) the levels of the [3H]TCDD-AhR complex (velocity sedimentation analysis), and (iii) the levels of nuclear AhR complex liganded with the antagonists [(i) - (iii)]. This study, coupled with the parallel structure-activity investigations with substituted analogs, will delineate the role of the nuclear AhR-antagonist complexes as inhibitors of TCDD-induced gene transcription (note: this will include Northern analysis of induced CYP1A1, aldehyde-3-dehydrogenase, plasminogen activator inhibitor-1 -and -2 mRNAs). The final component of Experiment 2 will characterize possible structural differences between AhR complexes liganded with antagonists or agonists. It has been shown that nuclear AhR complexes liganded with some model antagonists are formed in the model cell lines. Experiment 3 will utilize plasmids containing variable length DNA sequences from the 5'-flanking region of the CYP1A1 gene as probes for understanding the molecular mechanisms of AhR antagonists in the 4 model cell lines. Experiment 4 will test the hypothesis that the effects on chromatin structure by the nuclear AhR complex liganded with antagonists are different from those caused by the nuclear TCDD-AhR complex. TCDD- induced gene transcription may also be inhibited at the gene level by trans-acting repressor proteins which bind to cis-acting genomic elements. Preliminary studies in this laboratory have identified 3 cell lines which express the nuclear AhR complex but are not Ah-responsive. The proposed studies in Experiment 5 will utilize a series of plasmid constructs from the 5'-region of the human. CYP1A1 gene to probe the molecular biology of the negative regulation of AhR-mediated gene transcription in the MDA MB 2331, PEO1 and PEO6 human cancer cell lines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003843-10
Application #
2153465
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1986-07-01
Project End
1996-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Hoivik, D; Willett, K; Wilson, C et al. (1997) Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J Biol Chem 272:30270-4
Wilson, C L; Thomsen, J; Hoivik, D J et al. (1997) Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MDA-MB-231 cells is associated with expression of a variant arnt protein. Arch Biochem Biophys 346:65-73
Hoivik, D; Wilson, C; Wang, W et al. (1997) Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells. Arch Biochem Biophys 348:174-82
Lu, Y F; Santostefano, M; Cunningham, B D et al. (1996) Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochem Pharmacol 51:1077-87
Santostefano, M; Safe, S (1996) Characterization of the molecular and structural properties of the transformed and nuclear aryl hydrocarbon (Ah) receptor complexes by proteolytic digestion. Chem Biol Interact 100:221-40
Wang, W L; Thomsen, J S; Porter, W et al. (1996) Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Br J Cancer 73:316-22
Wang, X; Thomsen, J S; Santostefano, M et al. (1995) Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. Eur J Pharmacol 293:191-205
Lu, Y F; Santostefano, M; Cunningham, B D et al. (1995) Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch Biochem Biophys 316:470-7
Merchant, M; Safe, S (1995) In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct. Biochem Pharmacol 50:663-8
Wang, X; Safe, S (1994) Development of an in vitro model for investigating the formation of the nuclear Ah receptor complex in mouse Hepa 1c1c7 cells. Arch Biochem Biophys 315:285-92

Showing the most recent 10 out of 39 publications